Laumas Sandeep is a director of Unicycive Therapeutics Inc.
Person profile
Roles
Address
Raleigh, North Carolina
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
BioXcel Therapeutics, Inc.
11 Jun 24
4
Instil Bio, Inc.
13 Feb 24
4
Unicycive Therapeutics, Inc.
7 Sep 23
4
BioXcel Therapeutics, Inc.
28 Jun 23
4/A
Instil Bio, Inc.
20 Jan 23
4
Instil Bio, Inc.
20 Jan 23
4
BioXcel Therapeutics, Inc.
23 May 22
4
Instil Bio, Inc.
7 Mar 22
3
Hillstream BioPharma Inc.
11 Jan 22
3
Unicycive Therapeutics, Inc.
12 Jul 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Jun 24 | BTAI BioXcel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.44 | 17,000 | 24.48 k | 17,000 |
10 Feb 24 | TIL Instil Bio | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 11.6 | 80,000 | 928.00 k | 80,000 |
5 Sep 23 | UNCY Unicycive Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 0.76 | 189,236 | 143.82 k | 200,864 |
26 Jun 23 | BTAI BioXcel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 17.52 | 17,000 | 297.84 k | 17,000 |
8 Jan 23 | TIL Instil Bio | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.634 | 415,000 | 263.11 k | 415,000 |